Torrejón-Llorens, O, González-Casals, H, Soler, VG, Major, X, Briseño, R, Gàlvez, M, Lana, I, Garrido, A, Bartoli, M, Meroño, M, Expósito, U, Espelt, A, Martró, E, Folch, C. Community-based dried blood spot testing reveals substantial progress towards hepatitis C virus elimination in people who inject drugs in Catalonia. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Cerqueira-Silva, T, Boaventura, VS, Paixao, ES, Sanchez, M, Leyrat, C, Ranzani, O, Barreto, ML, Pescarini, JM. Long-term risk of death after tuberculosis diagnosis and treatment. NATURE MEDICINE. 2026; 32(5)DOI:10.1038/s41591-026-04294-w. PMID:41857197. IF:50.000(Q1/1D).

Berenguer, J, Ryan, P, Lutz, T, Carbonero, LM, Latorre, LP, Vivancos-Gallego, MJ, Navarro, J, Navarro, R, Ferrero, O, Muñoz, RP, Wyen, C, Domingo, P, Monin, M, Camino, X, Montero, M, Killer, A, Malin, J, de los Santos, I, Esser, S, Amado, LEM, López, I, Vogelmann, R, Mauss, S, Rivero, A, Elamouri, F, Hidalgo-Tenorio, C, van Bremen, K, Pérez-Somarriba, J, Sanz, J, Beer, D, Baumgarten, A, Haberl, A, Galindo, MJ, Fariñas, C, Voit, F, Qurishi, N, Noe, S, Bañuls, SR, Khaykin, P, Schneeweiss, SM, Boyd, A, De Miguel, M, Bellón, J, Rockstroh, J. Management of chronic hepatitis B in people with human immunodeficiency virus infection in Europe: real-world evidence from Spain and Germany. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Padilla-Lopez, M, Vaz-Romero, I, Ahumada, A, Merino, J, Grgurevic, I, Madir, A, Pastrovic, F, Morisco, F, Degasperi, E, Kupcinskas, L, Vindzgalskyte, R, Maderuelo, E, Ferris, NG, Herrera, EL, Dajti, E, Azzaroli, F, Fajardo, J, Brujats, A, Alvarado-Tapias, E, Madaleno, J, Verhelst, X, Papp, M, Bozso, B, de la Viña, D, Villamil, A, Bandi, JC, Arvaniti, P, Olivas, I, Evole, HH, Plaza, MS, Barciela, MR, Londoño, MC, Rodriguez-Tajes, S. Utility of spleen stiffness measurement for the detection of esophageal varices in primary biliary cholangitis (PBC). JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Younossi, ZM, de Avila, L, Petta, S, Hagström, H, Kim, SU, Nakajima, A, Crespo, J, Castera, L, Alkhouri, N, Zheng, MH, Treeprasertsuk, S, Ananchuensook, P, Shalimar, S, Tsochatzis, E, Shenoy, KT, Mohan, L, Fan, JG, Roberts, S, Alswat, KA, Wong, VWS, Yilmaz, Y, Dunn, W, Francque, S, Cordie, A, Yu, ML, Ekstedt, M, Goh, GBB, Oliveira, CP, Pessoa, M, Chan, WK, Fernández, MIC, Duseja, AK, Arab, JP, Papatheodoridis, G, Sebastiani, G, Villela-Nogueira, CA, D'Ambrosio, R, Lampertico, P, Al Naamani, K, Holleboom, AG, Valsan, A, Venu, A, El-Kassas, M, Pennisi, G, Shang, Y, Liu, WY, Lee, HW, Kobayashi, T, Kakizaki, S, Caussy, C, Pearlman, B, Iruzubieta, P, Nadeem, R, Cinque, F, Papatheodoridi, M, Zoncape, M, Yang, RX, Song, SJ, Dunn, N, Gadi, Z, Yeh, ML, Teh, KKJ, Mahadeva, S, Fabian, LG, Almohsen, A, Leite, N, Pugliese, N, Vessby, J, Xie, CC, Choudhary, NS, Friend, E, Poca, M, Kawaguchi, T, Russo, FP, Gadano, A, Diaz, LA, Singal, AK, Ségrestin, B, Gunn, N, Mauricio, D, Arrese, M, Fracanzani, AL, Lombardi, R, Aghemo, A, Lam, B, Khoja, B, Almuhaidib, S, Alqahtani, S, Racila, A, Stepanova, M. Clinical profile, histologic features, non-invasive test accuracy, and long-term outcomes of lean metabolic dysfunction associated steatotic liver disease (MASLD): insights from the global masld project. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

Diaz-Gonzalez, A, Montón, C, Brosell, M, Castiella, A, Torrente, S, Garcia-Retortillo, M, Villagrasa, A, Barciela, MR, Gómez-Dominguez, E, Almeida, AA, Del Barrio, M, Evole, HH, Rodriguez-Tajes, S, Monescillo, A, Cortes, MG, Ortiz, JPT, Sousa-Martin, JM, Herrojo, JA, Moya, AG, Alarcón, FC, Casado-Martin, M, Mateu, AR, Hernández-Guerra, M, Rios, MP, Medrano, IP, Quiñones, R, Vega, LA, Martinez, IE, Bernal, V, Bonilla, EF, Fernandez-Rodriguez, C, Conde, I, Diaz, R, Vidal, M, Lapeña, B, De la Cruz, G, Castello, I, Gimeno, NG, Plaza, MS, Fernández-Yunquera, A, Llinás, MS, Fernández-Bermejo, M, Trias, M, Muñoz, BM, Conejero, MDA, León, RR, Dueñas-Sánchez, E, Prieto, J, Vergara, M, Londoño, MC. Management of patients with primary biliary cholangitis in the post-obeticholic era: real-world effectiveness data on elafibranor and seladelpar from the ColHai registry. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).